Star Combo Pharma Ltd (S66.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 27,812 | 26,019 | 24,700 | 22,880 | 26,725 |
| Cost of Goods | 20,629 | 18,611 | 19,304 | 17,272 | 22,115 |
| Gross Profit | 7,182 | 7,408 | 5,397 | 5,608 | 4,609 |
| Operating Expenses | 8,559 | 7,505 | 4,564 | 6,553 | 7,348 |
| Operating Income | -1,376 | -96 | 832 | -944 | -2,738 |
| Interest Expense | 192 | 196 | 187 | 171 | 236 |
| Other Income | 6,881 | 1,294 | -4,100 | 34 | -4,489 |
| Pre-tax Income | 5,313 | 1,001 | -3,455 | -1,082 | -7,463 |
| Income Tax | 64 | 254 | 548 | -385 | 413 |
| Net Income Continuous | 5,249 | 747 | -4,003 | -696 | -7,876 |
| Net Income | $5,249 | $747 | $-4,003 | $-696 | $-7,876 |
| EPS Basic Total Ops | 0.04 | 0.01 | -0.03 | -0.01 | -0.06 |
| EPS Basic Continuous Ops | 0.04 | 0.01 | -0.03 | -0.01 | -0.06 |
| EPS Diluted Total Ops | 0.04 | 0.01 | -0.03 | -0.01 | -0.06 |
| EPS Diluted Continuous Ops | 0.04 | 0.01 | -0.03 | -0.01 | -0.06 |
| EBITDA(a) | $7,553 | $2,787 | $-2,528 | $-127 | $-6,395 |